These strong correlations between LCN2 and metabolic factors should be highlighted and considered in the search for therapeutic options for the treatment and prevention of dementia, considering that the onset and development of dementia are strongly related to metabolic disorders, including hyperglycemia and insulin resistance. This evidence concerns the gene LCN2 and metabolic disease.